FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006509301> ?p ?o ?g. }

• W2006509301 abstract "To compare standard-of-care grid laser photocoagulation versus intravitreal ranibizumab (IVR) versus a combination of both in the treatment of chronic (>3 months) macular oedema secondary to branch retinal vein occlusion.Prospective, randomized, multicentre clinical trial. Thirty patients with a best-corrected visual acuity (BCVA) between 20/320 and 20/40 were randomized 1:1:1 to receive grid laser or three monthly injections of 0.5 mg IVR or both followed by 3 months of observation.Mean change from baseline BCVA at month 6 was +2 letters [laser; 0.04 logMAR, 95% confidence interval (-0.17; 0.25)], +17 letters [IVR; 0.34 (0.19; 0.5)] and +6 letters [combination; 0.12 (0.01; 0.24)] (IVR versus laser p = 0.02 and IVR versus combination p = 0.02). At month 3, mean improvement in central retinal thickness (CRT) was 90.6 μm (laser) (-18.65; 199.8), 379.5 μm (IVR) (204.2; -554.8), and 248 μm (167.2; -328.8) (combination) (IVR versus laser p = 0.005, laser versus combination p = 0.02). During the observation period, CRT improved in laser [37.6 μm (-66.82; 142.0)], but deteriorated in IVR [-142.4 μm (-247.6; -37.16)] and combination [-171.7 μm (-250.4; -92.96)] (laser versus IVR p = 0.01, laser versus combination p = 0.002) indicating recurrent oedema. Less laser retreatments (at 8 weeks) were required in combination group (2/10) than grid group (7/10).Six-month results suggest that ranibizumab may be superior to grid laser in improving visual acuity. Grid combined with IVR neither enhanced functional and morphological improvement of IVR nor did it prevent or prolong recurrence of oedema. In IVR groups, CRT increased slowly after stopping injections, whereas improvement in visual acuity was sustained, indicating that morphological changes occur prior to functional impairment." @default.
• W2006509301 created "2016-06-24" @default.
• W2006509301 creator A5010137447 @default.
• W2006509301 creator A5015160966 @default.
• W2006509301 creator A5040661757 @default.
• W2006509301 creator A5061287178 @default.
• W2006509301 creator A5063141518 @default.
• W2006509301 creator A5069475078 @default.
• W2006509301 creator A5072580801 @default.
• W2006509301 creator A5082605838 @default.
• W2006509301 creator A5091571016 @default.
• W2006509301 date "2014-07-08" @default.
• W2006509301 modified "2023-09-27" @default.
• W2006509301 title "Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial" @default.
• W2006509301 cites W1965030185 @default.
• W2006509301 cites W1973041406 @default.
• W2006509301 cites W1981783036 @default.
• W2006509301 cites W1986476440 @default.
• W2006509301 cites W2022621467 @default.
• W2006509301 cites W2030611116 @default.
• W2006509301 cites W2031269803 @default.
• W2006509301 cites W2045675901 @default.
• W2006509301 cites W2049980296 @default.
• W2006509301 cites W2075780935 @default.
• W2006509301 cites W2141529239 @default.
• W2006509301 cites W2159391810 @default.
• W2006509301 cites W2324588265 @default.
• W2006509301 cites W2767447900 @default.
• W2006509301 cites W4229823998 @default.
• W2006509301 cites W4237391818 @default.
• W2006509301 cites W4250416245 @default.
• W2006509301 doi "https://doi.org/10.1111/aos.12488" @default.
• W2006509301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25042729" @default.
• W2006509301 hasPublicationYear "2014" @default.
• W2006509301 type Work @default.
• W2006509301 sameAs 2006509301 @default.
• W2006509301 citedByCount "45" @default.
• W2006509301 countsByYear W20065093012014 @default.
• W2006509301 countsByYear W20065093012015 @default.
• W2006509301 countsByYear W20065093012016 @default.
• W2006509301 countsByYear W20065093012017 @default.
• W2006509301 countsByYear W20065093012018 @default.
• W2006509301 countsByYear W20065093012019 @default.
• W2006509301 countsByYear W20065093012020 @default.
• W2006509301 countsByYear W20065093012021 @default.
• W2006509301 countsByYear W20065093012022 @default.
• W2006509301 crossrefType "journal-article" @default.
• W2006509301 hasAuthorship W2006509301A5010137447 @default.
• W2006509301 hasAuthorship W2006509301A5015160966 @default.
• W2006509301 hasAuthorship W2006509301A5040661757 @default.
• W2006509301 hasAuthorship W2006509301A5061287178 @default.
• W2006509301 hasAuthorship W2006509301A5063141518 @default.
• W2006509301 hasAuthorship W2006509301A5069475078 @default.
• W2006509301 hasAuthorship W2006509301A5072580801 @default.
• W2006509301 hasAuthorship W2006509301A5082605838 @default.
• W2006509301 hasAuthorship W2006509301A5091571016 @default.
• W2006509301 hasBestOaLocation W20065093011 @default.
• W2006509301 hasConcept C118487528 @default.
• W2006509301 hasConcept C126322002 @default.
• W2006509301 hasConcept C141071460 @default.
• W2006509301 hasConcept C168563851 @default.
• W2006509301 hasConcept C2776694085 @default.
• W2006509301 hasConcept C2777802072 @default.
• W2006509301 hasConcept C2778257484 @default.
• W2006509301 hasConcept C2778844676 @default.
• W2006509301 hasConcept C2780261187 @default.
• W2006509301 hasConcept C2780347916 @default.
• W2006509301 hasConcept C2781100027 @default.
• W2006509301 hasConcept C44249647 @default.
• W2006509301 hasConcept C71924100 @default.
• W2006509301 hasConceptScore W2006509301C118487528 @default.
• W2006509301 hasConceptScore W2006509301C126322002 @default.
• W2006509301 hasConceptScore W2006509301C141071460 @default.
• W2006509301 hasConceptScore W2006509301C168563851 @default.
• W2006509301 hasConceptScore W2006509301C2776694085 @default.
• W2006509301 hasConceptScore W2006509301C2777802072 @default.
• W2006509301 hasConceptScore W2006509301C2778257484 @default.
• W2006509301 hasConceptScore W2006509301C2778844676 @default.
• W2006509301 hasConceptScore W2006509301C2780261187 @default.
• W2006509301 hasConceptScore W2006509301C2780347916 @default.
• W2006509301 hasConceptScore W2006509301C2781100027 @default.
• W2006509301 hasConceptScore W2006509301C44249647 @default.
• W2006509301 hasConceptScore W2006509301C71924100 @default.
• W2006509301 hasIssue "1" @default.
• W2006509301 hasLocation W20065093011 @default.
• W2006509301 hasLocation W20065093012 @default.
• W2006509301 hasOpenAccess W2006509301 @default.
• W2006509301 hasPrimaryLocation W20065093011 @default.
• W2006509301 hasRelatedWork W1972614420 @default.
• W2006509301 hasRelatedWork W1997095687 @default.
• W2006509301 hasRelatedWork W2023340561 @default.
• W2006509301 hasRelatedWork W2137139667 @default.
• W2006509301 hasRelatedWork W2298380539 @default.
• W2006509301 hasRelatedWork W2588621177 @default.
• W2006509301 hasRelatedWork W3029290848 @default.
• W2006509301 hasRelatedWork W3031005433 @default.
• W2006509301 hasRelatedWork W3147589859 @default.
• W2006509301 hasRelatedWork W4205243730 @default.
• W2006509301 hasVolume "93" @default.
• W2006509301 isParatext "false" @default.

• next